4
Changes in Ownership
PALVELLA THERAPEUTICS, INC. Filed Acc 0001104659-26-076460
Chief Operating Officer sold 4,302 shares at an average $110.73 ($476,373)
- Chief Operating Officer acquired 4,302 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goin Kathleen · Chief Operating Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,154 | $7.14 | $15,380 | 2,154 | D |
| 2026-06-17 | Exercise or conversion : show line 2 in the form 10b5-1 | +2,148 | $9.08 | $19,504 | 4,302 | D |
| 2026-06-17 | Sale : show line 3 in the form 10b5-1 | −2,390 | $110.26 | $263,520 | 1,912 | D |
| 2026-06-17 | Sale : show line 4 in the form 10b5-1 | −1,887 | $111.31 | $210,047 | 25 | D |
| 2026-06-17 | Sale : show line 5 in the form 10b5-1 | −25 | $112.23 | $2,806 | 0 | D |
| Open-market sales · 4,302 sh · avg $110.73 · $476,373 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-17 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −2,154 | 8,627 | D |
| 2026-06-17 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −2,148 | 8,592 | D |
Loading xslF345X06/tm2618468-1_4seq1.xml…